Recarbrio 500 mg/500 mg/250 mg powder for solution for infusion
▼
Recarbrio is indicated for: • Treatment of hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP), in adults (see sections 4.4 and 5.1). • Treatment of bacteraemia that occurs in association with, or is suspected to be associated with HAP or VAP, in adults. • Treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options (see sections 4.2, 4.4, and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents.